Atsushi� Satake

1.1k total citations
72 papers, 697 citations indexed

About

Atsushi� Satake is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Atsushi� Satake has authored 72 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hematology, 34 papers in Immunology and 16 papers in Oncology. Recurrent topics in Atsushi� Satake's work include Hematopoietic Stem Cell Transplantation (21 papers), T-cell and B-cell Immunology (20 papers) and Immune Cell Function and Interaction (19 papers). Atsushi� Satake is often cited by papers focused on Hematopoietic Stem Cell Transplantation (21 papers), T-cell and B-cell Immunology (20 papers) and Immune Cell Function and Interaction (19 papers). Atsushi� Satake collaborates with scholars based in Japan, United States and Portugal. Atsushi� Satake's co-authors include Shosaku� Nomura, Tomoki� Ito, Taku Kambayashi, Hideaki� Yoshimura, Masaaki� Hotta, Shinya� Fujita, Kazuyoshi� Ishii, Aya Nakaya, Amanda M. Schmidt and Takahisa� Nakanishi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Atsushi� Satake

65 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Atsushi� Satake Japan	16	334	274	127	103	83	72	697
Leopold Oehler Austria	13	357 1.1×	192 0.7×	173 1.4×	154 1.5×	59 0.7×	21	762
Nina Pilat Austria	17	517 1.5×	205 0.7×	110 0.9×	88 0.9×	55 0.7×	57	947
Allan Thiolat France	13	374 1.1×	98 0.4×	139 1.1×	98 1.0×	69 0.8×	27	619
Emma Ross United Kingdom	7	272 0.8×	136 0.5×	108 0.9×	100 1.0×	56 0.7×	8	729
Silvana Compasso Italy	10	132 0.4×	115 0.4×	103 0.8×	161 1.6×	44 0.5×	10	489
M Kasai Japan	15	244 0.7×	431 1.6×	138 1.1×	52 0.5×	48 0.6×	41	716
Tommaso Stefanelli Italy	7	161 0.5×	259 0.9×	93 0.7×	63 0.6×	47 0.6×	24	490
Masaaki Noguchi Japan	14	163 0.5×	151 0.6×	180 1.4×	245 2.4×	145 1.7×	85	866
Eleonora Ballanti Italy	12	357 1.1×	121 0.4×	28 0.2×	90 0.9×	77 0.9×	18	649
Michael R. Clarkson United States	13	1.4k 4.2×	151 0.6×	232 1.8×	104 1.0×	130 1.6×	16	1.7k

Countries citing papers authored by Atsushi� Satake

Since Specialization

Citations

This map shows the geographic impact of Atsushi� Satake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi� Satake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi� Satake more than expected).

Fields of papers citing papers by Atsushi� Satake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsushi� Satake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi� Satake. The network helps show where Atsushi� Satake may publish in the future.

Co-authorship network of co-authors of Atsushi� Satake

This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi� Satake. A scholar is included among the top collaborators of Atsushi� Satake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsushi� Satake. Atsushi� Satake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yoshida, Yukari, et al.. (2023). ALLOANTIBODY-LIKE MIMICKING ANTI-c WITH BLOOD TRANSFUSION HISTORY AND AUTOANTIBODY-LIKE MIMICKING ANTI-E WITHOUT IMMUNE STIMULATION: TWO CASE REPORTS. Japanese Journal of Transfusion and Cell Therapy. 69(6). 653–657.

Yoshimura, Hideaki�, Atsushi� Satake, Jun Ichikawa, et al.. (2022). Real-world efficacy of letermovir prophylaxis for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: A single-center retrospective analysis. Journal of Infection and Chemotherapy. 28(9). 1317–1323. 15 indexed citations

Nakanishi, Takahisa�, Tomoki� Ito, Shinya� Fujita, et al.. (2020). Refractory Chronic Lymphocytic Leukemia with Central Nervous System Involvement: A Case Report with Literature Review. Journal of Blood Medicine. Volume 11. 487–502. 4 indexed citations

Matsui, Fumi, Muneo Inaba, Kazushige Uchida, et al.. (2018). Induction of PIR-A/B+ DCs in the in vitro inflammatory condition and their immunoregulatory function. Journal of Gastroenterology. 53(10). 1131–1141. 4 indexed citations

Ito, Tomoki�, Aya Nakaya, Shinya� Fujita, et al.. (2018). Secondary pure red cell aplasia in multiple myeloma treated with lenalidomide. Leukemia Research Reports. 10. 4–6. 4 indexed citations

Nomura, Shosaku�, Tomoki� Ito, Atsushi� Satake, & Kazuyoshi� Ishii. (2018). Assessment of soluble cytotoxic T lymphocyte-associated antigen-4, transforming growth factor β<sub>1</sub>, and platelet-derived microparticles during dasatinib therapy for patients with chronic myelogenous leukemia. Journal of Blood Medicine. Volume 10. 1–8. 6 indexed citations

Ito, Tomoki�, Akiko� Konishi, Masaaki� Hotta, et al.. (2018). Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective Study. Frontiers in Nutrition. 5. 72–72. 10 indexed citations

Ito, Tomoki�, Kayoko Kibata, Muneo Inaba, et al.. (2017). Lenalidomide Acts As a Positive Immunomodulator through Modulating the Functions of Human Plasmacytoid Dendritic Cells. Blood. 130. 1007–1007.

Takeyasu, Yuki, Atsushi� Satake, Hideaki� Yoshimura, et al.. (2017). Tyrosine kinase inhibitor and rituximab‐ CHOP treatment for concurrent chronic myeloid leukemia and non‐Hodgkin lymphoma: a case report. Clinical Case Reports. 5(12). 2047–2050. 3 indexed citations

10.

Nakaya, Aya, Shinya� Fujita, Atsushi� Satake, et al.. (2017). Upfront high-dose chemotherapy combined with autologous stem cell transplantation: Potential survival benefit for patients with high-risk diffuse large B-cell lymphoma. Oncology Letters. 14(3). 3803–3808. 5 indexed citations

11.

Nomura, Shosaku�, Kazuyoshi� Ishii, Shinya� Fujita, et al.. (2017). Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation. Transplant Immunology. 43-44. 27–32. 29 indexed citations

12.

Nakaya, Aya, Shinya� Fujita, Atsushi� Satake, et al.. (2017). Transplant-Ineligible Symptomatic but Indolent Multiple Myeloma Shows Better Prognosis with Conventional Agents. Case Reports in Oncology. 10(3). 871–875.

13.

Nakaya, Aya, Shinya� Fujita, Atsushi� Satake, et al.. (2017). Realistic Lenalidomide Dose Adjustment Strategy for Transplant-Ineligible Elderly Patients with Relapsed/Refractory Multiple Myeloma: Japanese Real-World Experience. Acta Haematologica. 138(1). 55–60. 7 indexed citations

14.

Satake, Atsushi�, Masaaki� Hotta, Hideaki� Yoshimura, et al.. (2016). Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia/lymphoma: a report of two cases. International Journal of Hematology. 104(6). 744–748. 5 indexed citations

15.

Nakaya, Aya, Masaaki� Hotta, Shinya� Fujita, et al.. (2016). Disseminated intravascular coagulation observed following treatment with gemtuzumab ozogamicin for relapsed/refractory acute promyelocytic leukemia. Molecular and Clinical Oncology. 5(1). 31–34. 2 indexed citations

16.

Nakaya, Aya, Shinya� Fujita, Atsushi� Satake, et al.. (2016). Delayed HBV reactivation in rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA?. Leukemia Research. 50. 46–49. 33 indexed citations

17.

Satake, Atsushi�, Amanda M. Schmidt, Shosaku� Nomura, & Taku Kambayashi. (2014). Inhibition of Calcineurin Abrogates While Inhibition of mTOR Promotes Regulatory T Cell Expansion and Graft-Versus-Host Disease Protection by IL-2 in Allogeneic Bone Marrow Transplantation. PLoS ONE. 9(3). e92888–e92888. 28 indexed citations

18.

Okada, Masaya, Atsushi� Satake, Katsuji Kaida, et al.. (2011). Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene. International Journal of Hematology. 93(2). 243–246. 4 indexed citations

19.

Okada, Masaya, Yoshihiro Fujimori, Mahito Misawa, et al.. (2008). Unrelated Umbilical Cord Blood Transplantation Using a TBI/FLAG Conditioning Regimen for Adults with Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 14(8). 896–903. 9 indexed citations

20.

Tabata, Masahiko, Atsushi� Satake, Akihiko Toda, et al.. (2002). Long-term outcome after allogeneic bone marrow transplantation for hematological malignancies with non-remission status. Annals of Hematology. 81(10). 582–587. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact